Benzinga’s Biggest Losers (BZ, ADSK, ILMN, CRM, NANO, ONCY)

Boise Inc. (NYSE: BZ) fell 5% to $4.85 huge volume of 8.37 million shares after Boise Inc. announced that the previously announced secondary offering of 17 million shares of its common stock has been priced at $4.85 per share. Pursuant to the offering, all of the shares will be sold by the selling stockholders, Boise Cascade Holdings, L.L.C. and trusts affiliated with Jason Weiss, one of Boise Inc.'s directors.

Autodesk, Inc. (NASDAQ: ADSK) plummeted 10% to $24.42 on 7.73 million shares after it gave a fourth-quarter earnings outlook on Tuesday that was lower than Wall Street expectations, and the software maker said that its recovery could be hindered by continued job losses in its core markets.

Illumina, Inc. (NASDAQ: ILMN) declined 8% to $28.74 on 5.49 million shares. So far this year the stock is up over 10%.

salesforce.com, inc. (NYSE: CRM) plunged 5% to $62.23 on volume of 2.71 million shares after it reported Q3 EPS of $0.16Vs the estimate of $0.16. Revenue for the quarter was $330.5 million against the estimate of $324.20 million. It sees Q4 EPS of $0.14-$0.15, versus the consensus of $0.15, on sales of $340-$342 million, versus the Street estimate of $ million.

Nanometrics Incorporated (NASDAQ: NANO) declined 10% to $11.78 on 1.62 million shares after it filed with the SEC a registration to sell at various times in one or more offerings of up to 6,200,000 shares of our common stock. Of these shares, 1,200,000 are being offered by the selling stockholder named in this prospectus and 5,000,000 are being offered by Nanometrics.

Oncolytics Biotech, Inc. (USA) (NASDAQ: ONCY) is trading at $2.88, decreased by $0.55 or 16.04% after announced today that it has entered into an underwriting agreement for an offering of 4,250,000 units, each comprised of one common share and 0.4 of a common share purchase warrant, at a price of $3.00 per unit to raise gross proceeds of $12,750,000.